Research Article
A Five-Gene Prognostic Nomogram Predicting Disease-Free Survival of Differentiated Thyroid Cancer
Table 2
Clinical baseline features of DTC patients in the training and testing datasets.
| Clinical features | Training dataset 305 | Testing dataset 128 | | % | | % |
| Cancer type, (%) | | | | | PTC | 247 | 80.98 | 104 | 81.25 | FTC | 58 | 19.02 | 24 | 18.75 | Age, (%) | | | | | ≤55 | 223 | 73.11 | 88 | 68.75 | >55 | 82 | 26.89 | 40 | 31.25 | Gender, (%) | | | | | Male | 79 | 25.90 | 39 | 30.47 | Female | 226 | 74.10 | 89 | 69.53 | Disease-free survival (year) () | | | | | Recurrence, (%) | | | | | Yes | 31 | 10.16 | 13 | 10.16 | No | 274 | 89.84 | 115 | 89.84 | Tumor size, (%) | | | | | ≤2 cm | 100 | 32.79 | 28 | 21.88 | >2 cm | 205 | 67.21 | 100 | 78.12 | N, (%) | | | | | N0 | 153 | 50.16 | 70 | 54.69 | N1 | 39 | 12.79 | 16 | 12.50 | N1a | 65 | 21.31 | 20 | 15.63 | N1b | 48 | 15.74 | 22 | 17.18 | M, (%) | | | | | M0 | 182 | 59.67 | 79 | 61.72 | M1 | 5 | 1.64 | 2 | 1.56 | MX | 118 | 38.69 | 47 | 36.72 | Anatomic site, (%) | | | | | Bilateral | 55 | 18.03 | 28 | 21.88 | Isthmus | 13 | 4.26 | 6 | 4.69 | Unilateral | 237 | 77.71 | 94 | 73.43 | Stage, (%) | | | | | Stage I | 177 | 58.03 | 70 | 54.69 | Stage II | 28 | 9.18 | 14 | 10.94 | Stage III | 68 | 22.30 | 27 | 21.09 | Stage IV | 32 | 10.49 | 17 | 13.28 | ATA risk stratification, (%) | | | | | High risk | 14 | 4.59 | 8 | 6.25 | Intermediate risk | 184 | 60.33 | 67 | 52.34 | Low risk | 107 | 35.08 | 53 | 41.41 | ETA risk stratification, (%) | | | | | High risk | 198 | 64.92 | 75 | 58.59 | Low risk | 100 | 32.79 | 48 | 37.50 | Very low risk | 7 | 2.29 | 5 | 3.91 |
|
|